Synthetic Peptides Induce a Cytotoxic Response against Human Papillomavirus Type-18

Author： Castellanos M.R. Hayes R.L. Maiman M.A.

Publisher： Elsevier

ISSN： 0090-8258

Source： Gynecologic Oncology, Vol.82, Iss.1, 2001-07, pp. : 77-83

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Vaccination against human papillomavirus types 16 and 18: the impact on cervical cancer

By Berkhof Johannes Bogaards Johannes A

Future Oncology, Vol. 6, Iss. 12, 2010-12 ,pp. : 1817-1821

Future Medicine

Access to resources Recommend Favorite

Regulation of Human Papillomavirus Type 18in Vivo:Effects of Estrogen and Progesterone in Transgenic Mice

By Michelin D. Gissmann L. Street D. Potkul R.K. Fisher S. Kaufmann A.M. Qiao L. Schreckenberger C.

Gynecologic Oncology, Vol. 66, Iss. 2, 1997-08 ,pp. : 202-208

Elsevier

Access to resources Recommend Favorite

Human papillomavirus type-distribution in cervical cancer in China: the importance of HPV 16 and 18

By Chen Wen

Cancer Causes and Control, Vol. 20, Iss. 9, 2009-11 ,pp. : 1705-1713

Springer Publishing Company

Access to resources Recommend Favorite

Cytostatic and cytotoxic activity of synthetic genistein glycosides against human cancer cell lines

By Polkowski K. Popiolkiewicz J. Krzeczynski P. Ramza J. Pucko W. Zegrocka-Stendel O. Boryski J. Skierski J.S. Mazurek A.P. Grynkiewicz G.

Cancer Letters, Vol. 203, Iss. 1, 2004-01 ,pp. : 59-69

Elsevier

Access to resources Recommend Favorite

Uterine Cervix Adenocarcinoma with both Human Papillomavirus Type 18 and Tumor Suppressor Gene p53 Mutation from a Woman Having an Intact Hymen

By Craigo J. Hopkins M. deLucia A.

Gynecologic Oncology, Vol. 59, Iss. 3, 1995-12 ,pp. : 423-426

Academic Press

Access to resources Recommend Favorite